
Sofosbuvir/velpatasvir for 12â¯weeks in genotype 1-4 HCV-infected liver transplant recipients
Keywords: غلظت NS5A; Direct-acting antiviral; Hepatitis C; Liver transplant; NS5A inhibitor; Sofosbuvir; Velpatasvir;